Antiviral Agents

Edit My Profile

"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Descriptor ID	D000998
MeSH Number(s)	D27.505.954.122.388
Concept/Terms	Antiviral Agents Antiviral Agents Agents, Antiviral Antivirals Antiviral Drugs Drugs, Antiviral

Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]

Below are MeSH descriptors whose meaning is related to "Antiviral Agents".

Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.

Bar chart showing 320 publications over 31 distinct years, with a maximum of 22 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	3	0	3
1996	7	2	9
1997	4	1	5
1998	9	3	12
1999	5	2	7
2000	4	1	5
2001	5	4	9
2002	5	4	9
2003	6	3	9
2004	9	3	12
2005	6	1	7
2006	8	4	12
2007	9	1	10
2008	8	1	9
2009	8	3	11
2010	9	3	12
2011	9	6	15
2012	7	4	11
2013	15	3	18
2014	8	6	14
2015	5	4	9
2016	5	6	11
2017	9	1	10
2018	4	3	7
2019	5	7	12
2020	12	10	22
2021	8	7	15
2022	4	15	19
2023	0	8	8
2024	4	3	7
2025	1	0	1

Below are the most recent publications written about "Antiviral Agents" by people in Profiles.

Juon HS, Yang D, Fang CX, Hann HW, Bae H, Chang M, Klassen AC. Perceived HBV-Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B. J Viral Hepat. 2025 Mar; 32(3):e70010.

View in: PubMed
Lingappa AF, Akintunde O, Samueli E, Ewald C, Michon M, Ziari N, Lu M, Yu SF, Froehlich M, Le PU, Fernandez Y, Mallesh S, Lin J, Kitaygorodskyy A, Solas D, Reed JC, Lingappa JR, M?ller-Schiffmann A, Korth C, Prasad D, Nalca A, Aston E, Fabbri B, Anand SK, Campi TW, Petrouski E, Dey D, Andrews DW, Rubenstein JL, Lingappa VR. Small molecule protein assembly modulators with pan-cancer therapeutic efficacy. Open Biol. 2024 Dec; 14(12):240210.

View in: PubMed
Prescott CR, Cohen EJ, Hochman JS, Troxel AB, Lu Y, Twi-Yeboah A, Jimenez CL, Mian SI, Mazen CY, Warner DB, Baratz KH, Jeng BH. Baseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study. Cornea. 2024 Dec 01; 43(12):1473-1480.

View in: PubMed
Jackson M, Ibrahim Y, Freeland C, Jacob S, Zovich B, Cohen C. Barriers to accessing hepatitis B medication: a qualitative study from the USA and Canada. BMJ Open. 2024 May 20; 14(5):e080658.

View in: PubMed
Maja AK, Gu D, Ge L, Lopez-Jimenez C, Cohen EJ, Zegans ME. Characteristics of Prescreened Patients Who Did Not Participate in the Zoster Eye Disease Study. Eye Contact Lens. 2024 Jul 01; 50(7):311-314.

View in: PubMed
Freidel MR, Armen RS. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike. Viruses. 2024 04 30; 16(5).

View in: PubMed
Freidel MR, Vakhariya PA, Sardarni SK, Armen RS. The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein. Viruses. 2024 04 20; 16(4).

View in: PubMed
Hegazy A, Soltane R, Alasiri A, Mostafa I, Metwaly AM, Eissa IH, Mahmoud SH, Allayeh AK, Shama NMA, Khalil AA, Barre RS, El-Shazly AM, Ali MA, Martinez-Sobrido L, Mostafa A. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle. BMC Complement Med Ther. 2024 Jan 22; 24(1):49.

View in: PubMed
Dar AA, Kim DD, Gordon SM, Klinzing K, Rosen S, Guha I, Porter N, Ortega Y, Forsyth KS, Roof J, Fazelinia H, Spruce LA, Eisenlohr LC, Behrens EM, Oliver PM. c-Myc uses Cul4b to preserve genome integrity and promote antiviral CD8+ T cell immunity. Nat Commun. 2023 Nov 04; 14(1):7098.

View in: PubMed
Gripp EW, Hess BD, Binder AF. Utility of Respiratory Pathogen Panels in the Outpatient Oncology Setting. Am J Med Qual. 2023 Nov 01; 38(6):294-299.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement